LIGAND PHARMACEUTICALS INCORPORATED
Patent Owner
Stats
- 44 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Aug 31, 2017 most recent publication
Details
- 44 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,317 Total Citation Count
- Dec 24, 1991 Earliest Filing
- 116 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2015/0071,857 STEROID HORMONE AND CHOLESTEROL PATHWAYS AS ONE UNIFIED HOMEOSTATIC SYSTEMMar 05, 13Mar 12, 15[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9675583 Selective androgen receptor modulators (SARMS) and uses thereofAug 14, 15Jun 13, 17[A61K, C07D]
9676809 Derivatives of uridine 5′-cyclophosphate useful to treat hepatitis C viral infectionsNov 19, 14Jun 13, 17[C07H]
9622991 Hematopoietic growth factor mimetic small molecule compounds and their usesMay 15, 15Apr 18, 17[A61K, C07D, C07C]
9492430 Methods and compositions associated with the granulocyte colony-stimulating factor receptorNov 12, 12Nov 15, 16[A61K, C12Q, C07D, A61N]
9359285 Androgen receptor modulator compounds and methodsOct 20, 14Jun 07, 16[A01N, C07F, C07D, C07C]
9144557 Hematopoietic growth factor mimetic small molecule compounds and their usesOct 12, 10Sep 29, 15[A61K, C07D, C07C]
9139520 Selective androgen receptor modulators (SARMs) and uses thereofApr 28, 14Sep 22, 15[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0356,325 NOVEL 2'-C-METHYL NUCLEOSIDE DERIVATIVE COMPOUNDSAbandonedJan 08, 13Dec 04, 14[C07H, A61K]
2014/0142,149 ORAL FORMULATIONS OF DIPHENYLSULFONAMIDE ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS TO TREAT ELEVATED BLOOD PRESSURE AND DIABETIC NEPHROPATHYAbandonedDec 19, 12May 22, 14[C07D]
2011/0224,153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related DisordersAbandonedApr 19, 10Sep 15, 11[A61K, A61P, C07K]
2011/0136,877 2-PHENYL PHENOXYACETIC ACIDS USEFUL FOR TREATING INFLAMMATORY DISORDERSAbandonedJan 06, 09Jun 09, 11[A61K, C07D, C07C, A61P]
2011/0112,084 Bicyclic androgen and progesterone receptor modulator compounds and methodsAbandonedNov 13, 09May 12, 11[A61K, C07D, A61P]
2011/0082,130 PIPERAZINYL OXOALKYL TETRAHYDROISOQUINOLINES AND RELATED ANALOGUESAbandonedAug 23, 10Apr 07, 11[A61K, C07D, A61P]
2010/0317,679 SUBSTITUTED ARYL-FUSED SPIROCYCLIC AMINESAbandonedSep 19, 08Dec 16, 10[A61K, C07D, G01N, A61P]
2010/0297,035 Thiazole Amides, Imidazole Amides and Related AnaloguesAbandonedApr 12, 10Nov 25, 10[A61K, C07D, G01N, A61P]
2010/0210,678 Tricyclic androgen receptor modulator compounds and methodsAbandonedMar 19, 10Aug 19, 10[A61K, C07D, A61P]
2010/0063,301 SYNTHESIS OF THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDSAbandonedMar 14, 07Mar 11, 10[C07D]
7662819 Pteridinone derivatives for use as stearoyl CoA desaturase inhibitorsExpiredOct 05, 07Feb 16, 10[A61K, C07D, A61P]
2009/0281,075 ISOMERIC PURINONES AND 1H-IMIDAZOPYRIDINONES AS PKC-THETA INHIBITORSAbandonedNov 07, 08Nov 12, 09[A61K, C07D, A61P]
2009/0227,571 Androgen Receptor Modulator Compounds and MethodsAbandonedJun 30, 06Sep 10, 09[A61K, C12Q, C12N, C07D, C07C]
2009/0203,725 Androgen Receptor Modulator Compounds and MethodsAbandonedDec 21, 06Aug 13, 09[A61K, C12N, C07D]
2009/0105,283 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORSAbandonedOct 15, 08Apr 23, 09[A61K, C07D]
2009/0105,292 Glucocorticoid Receptor Modulator Compounds and MethodsAbandonedFeb 24, 05Apr 23, 09[A61K, C07D]
2008/0300,241 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methodsAbandonedNov 17, 06Dec 04, 08[A61K, C07D]
7442696 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their usesExpiredJan 12, 07Oct 28, 08[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.